2025-521446-20-00招募中1 期
First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 64
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Liora Braiman
Scientific
Kamari Pharma Ltd.
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid TumorsNCT07265921Jiangsu Simcere Pharmaceutical Co., Ltd.232
招募中
1 期
Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.NCT07291323Janux Therapeutics60
招募中
2 期
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects with advanced solid tumors that cannot be removed with surgery or has spread locally or to other parts of the body.2023-505334-10-01Marengo Therapeutics Inc.46
招募中
1 期
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid TumorsNSCLCNCT07274813Shanghai Henlius Biotech254
招募中
1 期
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid TumorsNCT07288957Abbisko Therapeutics Co, Ltd266